Cancer biology and molecular genetics of A3 adenosine receptor

被引:0
|
作者
Chiara Mazziotta
John Charles Rotondo
Carmen Lanzillotti
Giulia Campione
Fernanda Martini
Mauro Tognon
机构
[1] University of Ferrara,Laboratories of Cell Biology and Molecular Genetics, Section of Experimental Medicine, Department of Medical Sciences, School of Medicine
[2] University of Ferrara,Center for Studies on Gender Medicine—Department of Medical Sciences
[3] University of Ferrara,Laboratory for Technologies of Advanced Therapies (LTTA)
来源
Oncogene | 2022年 / 41卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
A3 adenosine receptor (A3AR) is a cell membrane protein, which has been found to be overexpressed in a large number of cancer types. This receptor plays an important role in cancer by interacting with adenosine. Specifically, A3AR has a dual nature in different pathophysiological conditions, as it is expressed according to tissue type and stimulated by an adenosine dose-dependent manner. A3AR activation leads to tumor growth, cell proliferation and survival in some cases, while triggering cytostatic and apoptotic pathways in others. This review aims to describe the most relevant aspects of A3AR activation and its ligands whereas it summarizes A3AR activities in cancer. Progress in the field of A3AR modulators, with a potential therapeutic role in cancer treatment are reported, as well.
引用
收藏
页码:301 / 308
页数:7
相关论文
共 50 条
  • [1] Cancer biology and molecular genetics of A3 adenosine receptor
    Mazziotta, Chiara
    Rotondo, John Charles
    Lanzillotti, Carmen
    Campione, Giulia
    Martini, Fernanda
    Tognon, Mauro
    [J]. ONCOGENE, 2022, 41 (03) : 301 - 308
  • [2] The A3 adenosine receptor:: An enigmatic player in cell biology
    Gessi, Stefania
    Merighi, Stefania
    Varani, Katia
    Leung, Edward
    Mac Lennan, Stephen
    Borea, Pier Andrea
    [J]. PHARMACOLOGY & THERAPEUTICS, 2008, 117 (01) : 123 - 140
  • [3] MOLECULAR-CLONING AND CHARACTERIZATION OF AN ADENOSINE RECEPTOR - THE A3 ADENOSINE RECEPTOR
    ZHOU, QY
    LI, CY
    OLAH, ME
    JOHNSON, RA
    STILES, GL
    CIVELLI, O
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (16) : 7432 - 7436
  • [4] A3 adenosine receptor as a target for cancer therapy
    Fishman, P
    Bar-Yehuda, S
    Madi, L
    Cohn, I
    [J]. ANTI-CANCER DRUGS, 2002, 13 (05) : 437 - 443
  • [5] The A3 adenosine receptor as a new target for cancer therapy and chemoprotection
    Fishman, P
    Bar-Yehuda, S
    Barer, F
    Madi, L
    Multani, AS
    Pathak, S
    [J]. EXPERIMENTAL CELL RESEARCH, 2001, 269 (02) : 230 - 236
  • [6] Molecular modeling study on potent and selective adenosine A3 receptor agonists
    Dal Ben, Diego
    Buccioni, Michela
    Lambertucci, Catia
    Marucci, Gabriella
    Thomas, Ajiroghene
    Volpini, Rosaria
    Cristalli, Gloria
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2010, 18 (22) : 7923 - 7930
  • [7] Molecular recognition of 3′-modified adenosine neoligands to the human A3 adenosine receptor and its neoceptor.
    Kim, SK
    Gao, ZG
    Duong, HT
    Jeong, LS
    Jacobson, KA
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 229 : U120 - U120
  • [8] THE HUMAN A3 ADENOSINE RECEPTOR GENE
    MURRISON, E
    GOODSON, SJ
    HARRIS, CA
    EDBROOKE, MR
    [J]. BIOCHEMICAL SOCIETY TRANSACTIONS, 1995, 23 (02) : S270 - S270
  • [9] Cardioprotection with A3 adenosine receptor agonists
    Auchampach, JA
    [J]. DRUG DEVELOPMENT RESEARCH, 2002, 56 (04) : 550 - 550
  • [10] Allosteric modulators of the A3 adenosine receptor
    Jacobson, Kenneth A.
    IJzerman, Adriaan P.
    Auchampach, John A.
    Gao, Zhan-Guo
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2011, 242